# Glycemic Control to Prevent Cardiac Morbidity in Vascular Surgery

> **NCT00328094** · NA · TERMINATED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 242 (actual)

## Conditions studied

- Peripheral Vascular Disease
- Abdominal Aortic Aneurysm

## Interventions

- **DRUG:** continuous intravenous insulin infusion

## Key facts

- **NCT ID:** NCT00328094
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-03
- **Primary completion:** 2008-04
- **Final completion:** 2009-05
- **Target enrollment:** 242 (ACTUAL)
- **Why stopped:** The recruitment rate slowed considerably
- **Last updated:** 2013-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00328094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00328094, "Glycemic Control to Prevent Cardiac Morbidity in Vascular Surgery". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00328094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*